Indications
Nerve agent or organophosphate poisoning with signs of toxicity (DUMBELS)
Contraindications
Pralidoxime: documented hypersensitivity. Atropine: no absolute contraindications in ACLS, documented hypersensitivity otherwise
Adult dose
Dosed by severity. One DuoDote or ATNAA holds 2.1 mg atropine and 600 mg pralidoxime.
Mild: atropine 2 mg IM or by auto-injector. No pralidoxime in the mild table
Mild to moderate: atropine 2-4 mg IM or by auto-injector, plus pralidoxime 600 mg IM or one 600 mg auto-injector
Severe: atropine 6 mg IM or by auto-injector (three 2 mg auto-injectors), plus pralidoxime three auto-injectors (1800 mg)
Pregnant: same as adult
Geriatric or frail: mild, atropine 1 mg. Mild to moderate, atropine 2 mg plus pralidoxime 10 mg/kg IM or one auto-injector. Severe, atropine 2-4 mg plus pralidoxime 25 mg/kg IM or two to three auto-injectors (1200-1800 mg)
Repeat atropine until secretions dry. The total can exceed 20 mg. Do not use the combined auto-injector for more atropine once the recommended pralidoxime dose is given
Pediatric dose
Dosed by age and severity.
Mild: atropine 0.05 mg/kg IM (0-2 years), 1 mg (3-7 years, 13-25 kg), 2 mg (8-14 years, 26-50 kg). No pralidoxime in the mild table
Mild to moderate: atropine as for mild, plus pralidoxime 15 mg/kg IM. Ages 3-14 can get one 600 mg auto-injector instead
Severe: atropine 0.1 mg/kg IM (0-2 years), 0.1 mg/kg IM or 2 mg by auto-injector (3-7 years), 4 mg (8-14 years), 6 mg (14 and older). Pralidoxime 45 mg/kg IM, or one auto-injector (3-7 years), two auto-injectors, 1200 mg (8-14 years), three auto-injectors, 1800 mg (14 and older)
Combined auto-injectors lack FDA approval for children. They can still be considered for first treatment of severe symptoms at any age. A 600 mg pralidoxime auto-injector can be given to an infant over 12 kg
Route
IM by auto-injector. Both drugs can also go IV in the same doses, or IO, but IM is preferred because it avoids the delay of getting access
Special considerations
Atropine is the main antidote. Give it right away and keep repeating it. You judge the response by drying secretions and easier breathing. Do not go by heart rate or pupils.
Pralidoxime helps most when it goes in soon after exposure. Delay it and it has little effect.
Too much pralidoxime can cause severe hypertension, weakness, headache, tachycardia and vision problems in adults. In children it can cause profound weakness with respiratory depression.
With an auto-injector there's no dose to calculate. Remove the patient's clothing and wash the skin with soap and warm water.
Follow your local protocols. Sources: National Model EMS Clinical Guidelines (NASEMSO, 2022): Acetylcholinesterase Inhibitors (Carbamates, Nerve Agents, Organophosphates) Exposure. Levels from the National EMS Scope of Practice Model (2019).